Skip to main content
KESTRA MEDICAL TECHNOLOGIES, LTD. logo

KESTRA MEDICAL TECHNOLOGIES, LTD. — Investor Relations & Filings

Ticker · KMTS ISIN · BMG524411052 US Manufacturing
Open in API
Filings indexed 92 across all filing types
Latest filing 2025-03-03 Regulatory Filings
Country US United States of America
Listing US KMTS

About KESTRA MEDICAL TECHNOLOGIES, LTD.

https://kestramedical.com/

Kestra Medical Technologies is a medical device and digital healthcare company focused on protecting patients from Sudden Cardiac Arrest (SCA). The company develops the ASSURE® Cardiac Recovery System, a comprehensive solution featuring a Wearable Cardioverter Defibrillator (WCD). This system provides continuous monitoring of a patient's heart rhythm, autonomous detection of life-threatening arrhythmias, and delivers defibrillation therapy when necessary. The ASSURE platform is supported by the Kestra CareStation™, a remote patient data platform for clinicians, and a dedicated patient application designed to enhance engagement and compliance. Kestra's technology is intended for patients at elevated risk for SCA, such as those with heart failure or low left ventricular ejection fraction.

Recent filings

Filing Released Lang Actions
S-1/A
Regulatory Filings Classification · 100% confidence The document is an Amendment No. 2 to a Form S-1 Registration Statement filed with the SEC under the Securities Act of 1933. It includes exhibits, legal agreements, employment contracts, and consents from auditors. The Form S-1 is a registration statement used for initial public offerings or other securities registrations, not a financial report like an annual or quarterly report. The document is not a report itself but a regulatory filing related to securities registration. Therefore, it fits best under Regulatory Filings (RNS).
2025-03-03 English
Regulatory Filings 2025
Regulatory Filings Classification · 95% confidence The document is a letter from the company Kestra Medical Technologies, Ltd. responding to verbal comments from the SEC staff regarding their Registration Statement on Form S-1 filed on February 10, 2025, and an Amendment No. 1 filed on February 26, 2025. The letter addresses specific comments on disclosures in the Registration Statement and amendments made in response. It is a correspondence related to a registration statement filing, not the registration statement itself or a financial report. The document is short (4836 characters) and serves as a response letter to regulatory comments, which fits the category of Regulatory Filings (RNS) rather than a full report or prospectus. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-02-27 English
S-1/A
Capital/Financing Update Classification · 95% confidence The document is a Form S-1/A Registration Statement Amendment No. 1 filed with the SEC for Kestra Medical Technologies, Ltd. It is a preliminary prospectus related to an initial public offering (IPO) of common shares. The text includes detailed information about the offering, company background, risk factors, management, financial statements, and other disclosures typical of an IPO registration statement. This type of filing is a capital raising document used to register securities for public sale. It is not an annual report, earnings release, or any other type of financial or governance report. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains substantive content, not just an announcement or certification, supporting a high confidence score.
2025-02-26 English
S-1
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the U.S. Securities and Exchange Commission. It is a registration statement under the Securities Act of 1933 for an initial public offering (IPO) of Kestra Medical Technologies, Ltd. The document includes a prospectus with detailed information about the company, the offering, risk factors, management discussion and analysis, financial statements, and other disclosures typical of an IPO registration statement. This type of filing is not an annual report, earnings release, or any other report type listed in the categories. It is a capital markets filing related to the company's initial public offering and registration of securities. The closest fitting category from the provided list is "Capital/Financing Update (CAP)", which covers updates on company fundraising and financing activities. Therefore, the document should be classified as CAP with high confidence.
2025-02-10 English
Regulatory Filings 2025
Regulatory Filings Classification · 95% confidence The document is a letter from Kestra Medical Technologies, Ltd. responding to comments from the SEC staff regarding their Draft Registration Statement on Form S-1. It references Amendment No. 3 to the Draft Registration Statement and discusses detailed responses to SEC comments on disclosures, financial data, and accounting policies. The document is not the registration statement itself but a comment letter and response to the SEC. It is a regulatory correspondence related to a registration filing, not a financial report, earnings release, or other specific report type. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory documents that do not fit other categories.
2025-02-04 English
Capital/Financing Update 2025
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed confidentially with the U.S. Securities and Exchange Commission. It is a preliminary prospectus for an initial public offering (IPO) of Kestra Medical Technologies, Ltd. The document includes detailed information about the offering, company background, risk factors, management, financial statements, and other disclosures typical of an IPO registration statement. This type of filing is related to capital raising and financing activities, specifically the registration of securities for public sale. Therefore, it fits the category of Capital/Financing Update filings rather than an annual report, earnings release, or other categories.
2025-02-04 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.